{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:49:00Z","timestamp":1781192940241,"version":"3.54.1"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Age-related macular degeneration (AMD) is a leading cause of blindness among the elderly worldwide. Anti-vascular endothelial growth factor (anti-VEGF) injections remain the first-line therapy for AMD. However, their high cost and the need for frequent administration pose challenges to long-term adherence, highlighting the need for accessible and cost-effective preventive strategies. Emerging evidence suggests that traditional antidiabetic drugs, such as metformin, sulfonylureas, and thiazolidinediones, may offer neuroprotective benefits, opening new avenues for AMD prevention. Among these, metformin has emerged as the most promising candidate, demonstrating significant potential in reducing AMD risk, even at low cumulative doses, primarily through AMP-activated protein kinase (AMPK) activation. Sulfonylureas, although effective in stimulating insulin secretion, carry risks such as hypoglycemia, hyperinsulinemia, and a possible association with increased cancer risk. Similarly, thiazolidinediones, while improving insulin sensitivity, are associated with adverse effects, including cardiovascular risks and macular edema, limiting their broader application in AMD prevention. This paper explores the preventive potential and underlying mechanisms of these antidiabetic drugs in AMD and discusses the role of artificial intelligence in optimizing individualized prevention strategies. By advancing precision medicine, these approaches may improve public health outcomes and reduce the burden of aging-related vision loss.<\/jats:p>","DOI":"10.3389\/fphar.2024.1507860","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T04:26:26Z","timestamp":1733804786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration"],"prefix":"10.3389","volume":"15","author":[{"given":"Yating","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s40123-024-00960-9","article-title":"Burden of disease study of patients with neovascular age-related macular degeneration in Spain","volume":"13","author":"Abraldes","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jamaophthalmol.2023.5478","article-title":"Metformin use and age-related macular degeneration in patients without diabetes","volume":"142","author":"Aggarwal","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.13005\/bpj\/2699","article-title":"Genetic polymorphism in the organic cation transporters 1 (OCT1) gene and its effect on therapeutic efficacy and gastrointestinal side effects of metformin in patients with type 2 diabetes mellitus in basrah\/southern Iraq","volume":"16","author":"Aladhab","year":"2023","journal-title":"Biomed. Pharmacol. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.62.9.9","article-title":"Diabetes exacerbates the intraocular pressure-independent retinal ganglion cells degeneration in the DBA\/2J model of glaucoma","volume":"62","author":"Amato","year":"2021","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/15353702211069986","article-title":"Metformin and retinal diseases in preclinical and clinical studies: insights and review of literature","volume":"247","author":"Amin","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/eye.2015.159","article-title":"Defining response to anti-VEGF therapies in neovascular AMD","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye"},{"key":"B7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2020.10.003","article-title":"The antidiabetic drug glibenclamide exerts direct retinal neuroprotection","volume":"229","author":"Berdugo","year":"2021","journal-title":"Transl. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes, Obes. Metabolism"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1167\/iovs.18-26422","article-title":"The common antidiabetic drug metformin reduces odds of developing age-related macular degeneration","volume":"60","author":"Brown","year":"2019","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2020.07.010","article-title":"A cost-benefit analysis of VEGF-inhibitor therapy for neovascular age-related macular degeneration in the United States","volume":"223","author":"Brown","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-\u03b3 levels in microglia and inhibits TNF-\u03b1 production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/17425255.2018.1541981","article-title":"Metformin transporter pharmacogenomics: insights into drug disposition\u2014where are we now?","volume":"14","author":"Chan","year":"2018","journal-title":"Expert Opin. drug metabolism and Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol. Therapy-Nucleic Acids"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e108196","DOI":"10.1371\/journal.pone.0108196","article-title":"Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PloS one"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14336\/AD.2017.1202","article-title":"Metformin and the risk of dementia in type 2 diabetes patients","volume":"10","author":"Chin-Hsiao","year":"2019","journal-title":"Aging Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/ijms19010237","article-title":"Anesthetic preconditioning as endogenous neuroprotection in glaucoma","volume":"19","author":"Chou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"824885","DOI":"10.3389\/fphar.2021.824885","article-title":"Caffeine protects against retinal inflammation","volume":"12","author":"Conti","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/bjophthalmol-2021-320665","article-title":"Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials","volume":"107","author":"Core","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"Dallaglio","year":"2014","journal-title":"Carcinogenesis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. eye Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-816222-4.00010-1","article-title":"Age-related macular degeneration","volume-title":"Genetics and genomics of eye disease","author":"de Jong","year":"2020"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2024.03.024","article-title":"Mitochondrial quality control in non-exudative age-related macular degeneration: from molecular mechanisms to structural and functional recovery","volume":"219","author":"Dieguez","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13543784.2023.2196010","article-title":"Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease","volume":"32","author":"Dihoum","year":"2023","journal-title":"Expert Opin. Investigational Drugs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2337\/db22-0515","article-title":"Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy","volume":"72","author":"Dionysopoulou","year":"2023","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"838173","DOI":"10.3389\/fnagi.2022.838173","article-title":"Exploring the pharmacological potential of metformin for neurodegenerative diseases","volume":"14","author":"Du","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ph15010062","article-title":"Testing mitochondrial-targeted drugs in iPSC-RPE from patients with age-related macular degeneration","volume":"15","author":"Ebeling","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e38728","DOI":"10.1097\/MD.0000000000038728","article-title":"The role of oral metformin in preventing and treating age-related macular degeneration: a meta-analysis","volume":"103","author":"Elhalag","year":"2024","journal-title":"Medicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/1120672121997288","article-title":"Association of metformin and development of dry age-related macular degeneration in a US insurance claims database","volume":"32","author":"Eton","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-031-27681-1_12","article-title":"Repurposing drugs for treatment of age-related macular degeneration","volume-title":"Retinal degenerative diseases XIX: mechanisms and experimental therapy","author":"Francisco","year":"2023"},{"key":"B30","first-page":"74","article-title":"Age-related macular degeneration","volume":"59","author":"Gheorghe","year":"2015","journal-title":"Romanian J. Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0193031","DOI":"10.1371\/journal.pone.0193031","article-title":"Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo","volume":"13","author":"Han","year":"2018","journal-title":"PloS one"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1007\/s12035-022-02998-x","article-title":"Glibenclamide directly prevents neuroinflammation by targeting SUR1-TRPM4-mediated NLRP3 inflammasome activation in microglia","volume":"59","author":"He","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/aos.15655","article-title":"Association between oral metformin use and the risk of age-related macular degeneration: a systematic review with meta-analysis","volume":"101","author":"Holtz","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"413782","DOI":"10.1155\/2012\/413782","article-title":"The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese","volume":"2012","author":"Hsieh","year":"2012","journal-title":"J. Diabetes Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/etm.2023.12227","article-title":"Metformin regulates the LIN28B-mediated JNK\/STAT3 signaling pathway through miR-140-3p in subretinal fibrosis","volume":"26","author":"Hua","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1275095","DOI":"10.3389\/fphar.2023.1275095","article-title":"Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2023.01.014","article-title":"Impact of age-related macular degeneration and related visual disability on the risk of depression: a nationwide cohort study","volume":"130","author":"Hwang","year":"","journal-title":"Ophthalmology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/iovs.64.10.10","article-title":"Diabetes-related risk factors for exudative age-related macular degeneration: a nationwide cohort study of a diabetic population","volume":"64","author":"Hwang","year":"","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4239\/wjd.v12.i7.916","article-title":"Long-term metformin therapy and vitamin B12 deficiency: an association to bear in mind","volume":"12","author":"Infante","year":"2021","journal-title":"World J. diabetes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/antiox10050790","article-title":"Oxidative stress and inflammation in retinal degeneration","volume":"10","author":"Jadeja","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e054420","DOI":"10.1136\/bmjopen-2021-054420","article-title":"Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study","volume":"12","author":"Jiang","year":"2022","journal-title":"BMJ open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0119708","DOI":"10.1371\/journal.pone.0119708","article-title":"Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1","volume":"10","author":"Joe","year":"2015","journal-title":"PloS one"},{"key":"B44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.64.11.22","article-title":"Association of metformin and other diabetes medication use and the development of new-onset dry age-related macular degeneration: a case\u2013control study","volume":"64","author":"Kaufmann","year":"2023","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/IAE.0000000000003968","article-title":"Association of metformin use with risk of newly onset neovascular age-related macular degeneration development","volume":"10","author":"Khanna","year":"2022","journal-title":"Retina"},{"key":"B46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40360-017-0169-y","article-title":"Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation","volume":"18","author":"Ku","year":"2017","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bjophthalmol-2019-314422","article-title":"Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis","volume":"104","author":"Li","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"111286","DOI":"10.1016\/j.biopha.2021.111286","article-title":"The effects of metformin on autophagy","volume":"137","author":"Lu","year":"2021","journal-title":"Biomed. and Pharmacother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.apmt.2021.101156","article-title":"Targeting nanocomposites with anti-oxidative\/inflammatory\/angiogenic activities for synergistically alleviating macular degeneration","volume":"24","author":"Luo","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e11349","DOI":"10.1097\/MD.0000000000011349","article-title":"Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: a systematic review","volume":"97","author":"Mato","year":"2018","journal-title":"Medicine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/s41598-019-51777-7","article-title":"Proteome and secretome dynamics of human retinal pigment epithelium in response to reactive oxygen species","volume":"9","author":"Meyer","year":"2019","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"167313","DOI":"10.1016\/j.bbadis.2024.167313","article-title":"Metformin instigates cellular autophagy to ameliorate high-fat diet-induced pancreatic inflammation and fibrosis\/EMT in mice","volume":"1870","author":"Mitra","year":"2024","journal-title":"Biochimica Biophysica Acta Mol. Basis Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/iovs.65.3.23","article-title":"The association between metformin use and new-onset ICD coding of geographic atrophy","volume":"65","author":"Moir","year":"2024","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6856\/FJEM.201405_5(S).0002","article-title":"A review on the clinical safety of thiazolidinediones","volume":"5","author":"Nien","year":"2014","journal-title":"Formos. J. Endocrinol. Metabolism"},{"key":"B57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.10026","article-title":"Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF","volume":"189","author":"Ohno-Matsui","year":"2001","journal-title":"J. Cell. physiology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10456-005-9027-4","article-title":"PPAR $$\\upgamma$$ represses VEGF expression in human endometrial cells: implications for uterine angiogenesis","volume":"8","author":"Peeters","year":"2006","journal-title":"Angiogenesis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.trsl.2024.05.002","article-title":"Glyburide confers neuroprotection against age-related macular degeneration (AMD)","volume":"272","author":"Picard","year":"2024","journal-title":"Transl. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.3390\/molecules26154673","article-title":"Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: in vivo evidence","volume":"26","author":"Puglia","year":"2021","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.arr.2024.102439","article-title":"Emerging role of Metformin in Alzheimer\u2019s disease: a translational view","volume":"100","author":"R\u00edos","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40123-021-00344-3","article-title":"Metformin, a potential role in age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Romdhoniyyah","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010919-023746","article-title":"Artificial intelligence in drug treatment","volume":"60","author":"Romm","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e68550","DOI":"10.7759\/cureus.68550","article-title":"Vitamin B12 deficiency in patients taking metformin: pathogenesis and recommendations","volume":"16","author":"Shahjahan","year":"2024","journal-title":"Cureus"},{"key":"B66","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00592-021-01833-4","article-title":"Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients","volume":"59","author":"Shao","year":"2022","journal-title":"Acta Diabetol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"100440","DOI":"10.1016\/j.xops.2023.100440","article-title":"METformin for the MINimization of geographic atrophy progression (METforMIN): a randomized trial","volume":"4","author":"Shen","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","article-title":"EMT and EndMT: emerging roles in age-related macular degeneration","volume":"21","author":"Shu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/OPTH.S185052","article-title":"The burden of neovascular age-related macular degeneration: a patient\u2019s perspective","volume":"12","author":"Spooner","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/geroni\/igac059.1639","article-title":"Depression, inflammation, and the moderating role of metformin: results from the midus study","volume":"6","author":"Syed","year":"2022","journal-title":"Innovation Aging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1073\/pnas.0504759102","article-title":"Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response","volume":"102","author":"Tian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/cells13171433","article-title":"Metformin alleviates inflammation and induces mitophagy in human retinal pigment epithelium cells suffering from mitochondrial damage","volume":"13","author":"Toppila","year":"2024","journal-title":"Cells"},{"key":"B73","first-page":"770","article-title":"Risk factors for hyperinsulinemia in chlorpropamide-treated diabetic patients: a three-year follow-up","volume":"91","author":"Tseng","year":"1992","journal-title":"J. Formos. Med. Assoc."},{"key":"B74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jfma.2011.10.003","article-title":"Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?","volume":"111","author":"Tseng","year":"2012","journal-title":"J. Formos. Med. Assoc."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e008860","DOI":"10.1161\/JAHA.118.008860","article-title":"Metformin and risk of hypertension in Taiwanese patients with type 2 diabetes mellitus","volume":"7","author":"Tseng","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e011640","DOI":"10.1161\/JAHA.118.011640","article-title":"Metformin use is associated with a lower risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: a retrospective cohort analysis","volume":"8","author":"Tseng","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B77","doi-asserted-by":"publisher","first-page":"592901","DOI":"10.3389\/fmed.2020.592901","article-title":"Metformin use is associated with a lower incidence of hospitalization for atrial fibrillation in patients with type 2 diabetes mellitus","volume":"7","author":"Tseng","year":"","journal-title":"Front. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjaa136","article-title":"Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus","volume":"15","author":"Tseng","year":"","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/ph16020224","article-title":"The risk of age-related macular degeneration is reduced in type 2 diabetes patients who use metformin","volume":"16","author":"Tseng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B80","doi-asserted-by":"publisher","first-page":"132400","DOI":"10.1016\/j.ijcard.2024.132400","article-title":"Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and\/or acute coronary syndrome: a neglected clinical scenario and the potential role of insulin","volume":"414","author":"Tseng","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e31266","DOI":"10.1097\/MD.0000000000031266","article-title":"Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema","volume":"101","author":"Uwimana","year":"2022","journal-title":"Medicine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1080\/0886022X.2016.1216723","article-title":"Metformin-related lactic acidosis: is it a myth or an underestimated reality?","volume":"38","author":"Visconti","year":"2016","journal-title":"Ren. Fail."},{"key":"B83","doi-asserted-by":"publisher","first-page":"108763","DOI":"10.1016\/j.exer.2021.108763","article-title":"Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK\/TGF-\u03b2\/Smad2\/3 signalling pathway","volume":"212","author":"Wang","year":"2021","journal-title":"Exp. Eye Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3892\/ijmm.2016.2724","article-title":"Importance of the interaction between immune cells and tumor vasculature mediated by thalidomide in cancer treatment (Review)","volume":"38","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"B86","first-page":"3873","article-title":"MiRNA-24 represses TGF-\u03b22 induced epithelial-mesenchymal transition (EMT), endothelial-mesenchymal transition (EndMT), and fibrosis program","volume":"63","author":"Wu","year":"2022","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"10475","DOI":"10.1073\/pnas.1802724115","article-title":"Stimulation of AMPK prevents degeneration of photoreceptors and the retinal pigment epithelium","volume":"115","author":"Xu","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.07.017","article-title":"The direct targets of metformin in diabetes and beyond","author":"Yao","year":"2024","journal-title":"Trends Endocrinol. Metabolism"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3578702","DOI":"10.1155\/2017\/3578702","article-title":"A protective role of glibenclamide in inflammation-associated injury","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"B91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.64.15.21","article-title":"Oral metformin inhibits choroidal neovascularization by modulating the gut-retina Axis","volume":"64","author":"Zhang","year":"2023","journal-title":"Investigative Ophthalmol. and Vis. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2524174","article-title":"Protective effect of metformin against hydrogen peroxide-induced oxidative damage in human retinal pigment epithelial (RPE) cells by enhancing autophagy through activation of AMPK pathway","volume":"2020","author":"Zhao","year":"2020","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1507860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T04:26:35Z","timestamp":1733804795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1507860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":92,"alternative-id":["10.3389\/fphar.2024.1507860"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1507860","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"article-number":"1507860"}}